Published in BMJ on August 21, 2004
Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa. Afr Health Sci (2005) 0.85
Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience. Springer Semin Immunopathol (2006) 0.81
Private sector needs incentives for AIDS vaccine. BMJ (2004) 0.75
Public health. A sound rationale needed for phase III HIV-1 vaccine trials. Science (2004) 5.31
Medicine. The need for a global HIV vaccine enterprise. Science (2003) 4.70
Policy rebuttal. HIV vaccine trial justified. Science (2004) 2.49
Cost-effectiveness of three different vaccination strategies against measles in Zambian children. Vaccine (2004) 1.37
The clades of HIV: their origins and clinical significance. AIDS Rev (2004) 1.09
Panel discussion on vaccine development to meet U.S. and international needs. Strategies for reducing the disincentives to HIV vaccine development: description of a successful public-private sector international collaboration. AIDS Res Hum Retroviruses (1994) 0.95